Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.
Background.Influenza A viruses cause occasional pandemics and frequent epidemics. Licensed influenza vaccines that induce high antibody titers to the highly polymorphic viral surface antigen hemagglutinin must be re-formulated and readministered annually. A vaccine providing protective immunity to the highly conserved internal antigens could provide longer-lasting protection against multiple influenza subtypes.
Methods.We pre... Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
(Version of record, pdf, 187.7KB)
- Publisher copy:
- Oxford University Press Publisher's website
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Journal website
- Publication date:
- Source identifiers:
- Local pid:
- Deposit date:
- Copyright holder:
- Berthoud et al
- Copyright date:
- Copyright Berthoud et al. 2013. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
If you are the owner of this record, you can report an update to it here: Report update to this record